Altogether these results suggest that, with 90% inhibition of SGLT2, SGLT1 barely compensates for the blockade of SGLT2 in diabetes, because hyperglycemia and the increased tubular glucose load already consume the full transport capacity of SGLT1 in the absence of SGLT2 inhibition. This evidence concerns the gene SLC5A2 and diabetes mellitus.